<DOC>
	<DOCNO>NCT01388907</DOCNO>
	<brief_summary>The purpose study evaluate clinically efficacy PREVADH® Film prevention adhesion gynaecologic surgery , assess post-operative complication related adhesion pregnancy rate myomectomy open surgery .</brief_summary>
	<brief_title>Efficacity Assessment PREVADH® Adhesion Prevention Gynaecologic Surgery</brief_title>
	<detailed_description>This study address patient immediate differed pregnancy desire present symptomatic asymptomatic fibroma able interfere fertility . - The primary end point assessment adhesion rate uterine surgical site laparoscopic second look perform 10 20 week post-surgery . - The secondary end point assessment , throughout 3 year follow-up period , : - pregnancy rate , - adverse event related adhesion , - adnexal adhesion accord American Fertility Society score , - abdomino-pelvic adhesion accord modified American Fertility Society score .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Symptomatic ( ) asymptomatic ( ) uterin ( ) fibroma ( ) able interfere fertility patient immediate differ desire pregnancy . Size : diameter ≥ 6 cm echographia ( high diameter ) Location interstitial / subserosa plan laparotomic surgery negative pregnancy test within 48 hour surgery sign inform consent History abdominopelvic surgery ( except appendicectomy cesarotomy ) Preoperative embolization Endometriosis stage &gt; 1 ( American Fertility Society classification ≥ 5 ) Pregnant patient Diabetes Chronic corticotherapy / immunosupressor immunomodulator drug Previous analog LHRH drug therapy uterine myoma</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>myomectomy</keyword>
	<keyword>adhesion prevention</keyword>
	<keyword>pregnancy rate</keyword>
</DOC>